Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-06-27 @ 8:04 AM
Study NCT ID:
NCT00433160
Status:
COMPLETED
Last Update Posted:
2010-09-21
First Post:
2007-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Clinical Trial of Teriparatide in Japan
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
10494
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
Eli Lilly